首页> 外文期刊>Saudi Journal of Gastroenterology >Comparison of long-term efficacy between endoscopic and percutaneous biliary drainage for resectable extrahepatic cholangiocarcinoma with biliary obstruction: A systematic review and meta-analysis
【24h】

Comparison of long-term efficacy between endoscopic and percutaneous biliary drainage for resectable extrahepatic cholangiocarcinoma with biliary obstruction: A systematic review and meta-analysis

机译:内镜和经皮胆道引流治疗可切除性肝外胆管癌合并胆道梗阻的远期疗效比较:系统评价和荟萃分析

获取原文
           

摘要

Background/Aim: For resectable extrahepatic cholangiocarcinoma with biliary obstruction, it remains a controversy whether to choose percutaneous transhepatic biliary drainage (PTBD) or endoscopic biliary drainage (EBD). A systematic review was conducted to compare the long-term efficacy between the two techniques. Materials and Methods: Eligible studies were searched from January 1990 to May 2018, comparing the long-term efficacy between EBD and PTBD for extrahepatic cholangiocarcinoma. Primary end point was overall survival (OS) rate, and secondary end points included postoperative severe complications and seeding metastasis. Effect size on outcomes was calculated using a fixed- or random-effect model, accompanied with hazard ratio (HR) and 95% confidence interval (CI). Result: Six studies were included in this meta-analysis. Meta-analysis showed that EBD was superior to PTBD in OS (HR = 0.70, 95% CI 0.59–0.84,P= 0.0002). But subgroup results showed that the superiority disappeared in distal cholangiocarcinoma (HR = 0.76, 95% CI 0.56–1.01,P= 0.06). Other prognostic factors such as intraoperative blood transfusion, lymphatic metastasis and seeding metastasis, were inconsistent between groups. In addition, regional disparity was obviously apparent between Japanese and non-Japanese studies. Conclusion: The conclusion that EBD was superior to PTBD in OS for resectable extrahepatic cholangiocarcinoma with biliary obstruction is less convincing, and more trials need to be conducted in future.
机译:背景/目的:对于可切除的胆道梗阻性肝外胆管癌,是否选择经皮肝穿胆道引流术(PTBD)或内镜胆道引流术(EBD)仍存在争议。进行了系统的审查,以比较两种技术之间的长期疗效。材料和方法:检索1990年1月至2018年5月的合格研究,比较EBD和PTBD对肝外胆管癌的长期疗效。主要终点是总体生存率,次要终点包括术后严重并发症和播种转移。使用固定或随机效应模型计算结果对结局的影响大小,并附带风险比(HR)和95%置信区间(CI)。结果:这项荟萃分析包括六项研究。荟萃分析显示,在OS中EBD优于PTBD(HR = 0.70,95%CI 0.59–0.84,P = 0.0002)。但是亚组结果显示优势在远端胆管癌中消失(HR = 0.76,95%CI 0.56-1.01,P = 0.06)。两组之间的其他预后因素如术中输血,淋巴结转移和种子转移均不一致。此外,日本和非日本研究之间的地区差异明显。结论:对于可切除的肝外胆管癌伴胆管梗阻,EBD在OS方面优于PTBD的结论缺乏说服力,今后还需要进行更多试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号